Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1193 (LINC01193)

Target
LINC01193
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1193 (LINC01193) is a human long non-coding RNA (lncRNA) annotated as "cancer/testis antigen 60 (non-protein coding)" and referenced as LOC348120 and CT60 in genomic databases[3]. It is encoded on chromosome 1. LINC01193 belongs to the molecular class of lncRNAs, which are RNA molecules longer than 200 nucleotides that do not encode proteins and are increasingly recognized for diverse regulatory roles in gene expression. As of current data, there is no experimentally validated function or mechanistic role described for LINC01193 in cellular biology or disease. Its nomenclature suggests it may be included in the family of cancer/testis antigens (CTAs), which are typically notable for restricted expression in testis and, aberrantly, in various cancers. However, no specific evidence is available to confirm that LINC01193 is expressed in cancer, nor are there reports of it serving as a biomarker or a therapeutic target[3]. In summary, LINC01193 is a human lncRNA with annotation links to the cancer/testis antigen family, but with no established function, role in disease, drug interaction, or utility as a biomarker as of current knowledge.

Other names
LOC348120CT60cancer/testis antigen 60 (non-protein coding)LINC01193[3]
02

Mechanism of action

Not applicable (no known drugs or interventions target this lncRNA)

03

Biological functions

Other (No specific functions described in the literature as of current knowledge)
04

Disease associations

Cancer (classified by homology/annotation as a cancer/testis antigen, but direct evidence regarding function is lacking)[3]Other (Potential relevance in tumor biology as inferred from classification, but not substantiated by functional data)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1193 (LINC01193).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1193 (LINC01193).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call